Newsroom

Sorted by: Latest

-

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer

TOKYO--(BUSINESS WIRE)--Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2+ eBC...
-

Weave Ranks No. 1 in G2's Fall 2026 Patient Relationship Management Grid Report

LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, has been named the No. 1 Leader in G2's Fall 2026 Grid® Report for Patient Relationship Management (PRM) software, earning the highest satisfaction score and largest market presence of any product in the category. In G2's verified reviews, 94% of users rated Weave 4 or 5 stars, and 96% said the product is headed in the right direction. "Ranking N...
-

Amulet Capital Promotes Sam Brinkley to Partner

GREENWICH, Conn.--(BUSINESS WIRE)--Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the promotion of Sam Brinkley to Partner. “Since joining Amulet, Sam has been an important member of our investment team and has worked closely with our partner / portfolio companies to drive key growth and operational priorities,” said Ramsey Frank, CEO of Amulet. “His partnership mindset, disciplined execution,...
-

Children’s Hospital Los Angeles Earns Top National and Global Pediatric Hospital Honors from U.S. News & World Report and Newsweek

LOS ANGELES--(BUSINESS WIRE)--CHLA ranks among the nation’s top 10 pediatric hospitals and No. 1 in California, and is ranked No. 5 worldwide in pediatrics by Newsweek....
-

ReposiTrak, Inc. Declares Quarterly Cash Dividend

SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak, Inc. (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today declared a quarterly dividend of $0.02 per quarter ($0.08 per share annually) to shareholders of record on September 30, 2026. The cash dividends will be paid to shareholders of record on or about November 13, 2026. Subsequent dividends will be paid within 45 days of eac...
-

H2O Care Partners Expands Footprint Through Four New Partnerships

BOSTON--(BUSINESS WIRE)--H2O Care Partners (“H2OCP”), a fast-growing water solutions platform, announced the acquisition of four new partner companies in April: American Pump & Drilling (“APD”) (WA), Beauchamp Water Treatment Solutions (“Beauchamp”) (MI), Universal Water Systems and Superior Water Treatment (“U&S”) (CO, NM, AZ), and Certain Services (FL). The partnerships extend H2OCP’s reach into the Southwest and Pacific Northwest, while deepening its presence in Michigan and Florida....
-

REJUVENATION OPENS NEW STORE IN DALLAS

PORTLAND, Ore.--(BUSINESS WIRE)--Rejuvenation, a portfolio brand of Williams-Sonoma, Inc. (NYSE: WSM), the world’s largest digital-first, design-led and sustainable home retailer, announced today, the opening of the brand’s new retail store in Dallas, Texas. Located in Inwood Village, the new 7,000-square-foot space will showcase Rejuvenation's signature assortment of lighting, hardware, bath collections, furniture, textiles, mirrors, and one-of-a-kind vintage finds. The new Rejuvenation Dallas...
-

Tunica-Biloxi Tribe Launches the First Tribal Nation Prediction Market App

MARKSVILLE, La.--(BUSINESS WIRE)--The Tunica-Biloxi Tribe of Louisiana today announced the launch of the first tribal prediction market app through SaltTrade Derivatives, a newly established subdivision of a Tribal-owned enterprise. The new app will be powered by Kalshi. The partnership marks another significant step in the Tribe’s ongoing work to exercise its economic independence, diversify its portfolio, and build sustainable sources of revenue for future generations. It creates a path for o...
-

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined wit...
-

Joby Completes First-Ever Fully Autonomous Flight Across the United States

SANTA CRUZ, Calif.--(BUSINESS WIRE)--Joby Aviation, Inc. (NYSE: JOBY) today announced that an aircraft equipped with its autonomy technology has completed the first-ever autonomous flight across the United States. The aircraft flew 3,199 miles with zero control inputs from its onboard safety pilot, concluding the eastbound leg of its month-long tour in North Carolina’s Outer Banks, near the site of the Wright brothers’ first powered flight. The aircraft, a converted Cessna Caravan, performed au...